Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Melco Announces Unaudited Third Quarter 2025 Earnings
-
Skyworks Introduces New Programmable Bulk Acoustic Wave Clocks for 5G, 6G, and Data Center Applications
-
Form 8.3 - IDOX plc - Octopus Investments
-
MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
-
BioCryst Presents New Data at ACAAI Highlighting Burden of HAE on Pediatric Patients and Caregivers and Sustained Reduction of Attacks in Children Treated with One Year of ORLADEYO® (berotralstat)
-
Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025
-
Asure Software Sets November and December 2025 Investor Conference Schedule
-
Annovis Achieves Significant Milestones and Sustains Strong Progress in Phase 3 Alzheimer’s Program
-
*MEDIA ALERT* Verizon and David Beckham Launch First-Ever "Golden Ticket" Sweepstakes for FIFA World Cup 26™
-
SunCar’s Investment in its AI Technology Development Center Driving Strong Premium Sales for its EV Partners
-
GraniteShares Announces Weekly Distributions for its YieldBOOST ETFs: COYY, TSYY, NVYY, XBTY, AMYY, TQQY, AZYY, YSPY, MTYY, PLYY, HOYY, SMYY, BBYY, FBYY, IOYY and MAAY
-
SharpLink to Host Third Quarter 2025 Financial Results Conference Call and Webcast on November 13, 2025 at 8:30 A.M. E.T.
-
Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis
-
LiveOne (Nasdaq: LVO) to Announce Its Second Quarter Fiscal Year 2026 Financial Results and Host Investor Webcast on November 12, 2025, at 10:00 am Eastern Time (7:00 am Pacific Time)
-
LM Funding Announces Third Quarter 2025 Earnings Call for November 14, 2025
-
Workhorse Group Reminds Shareholders to Vote Today FOR All Proposals
-
Locafy Reports Strong Commercial Momentum Going into CY 2026
-
RAPT Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
-
Healthcare Minus the Headache: RokketMed, A Solution to Finding the Care That Counts
-
PDS Biotech Announces Conference Call and Webcast for Third Quarter 2025 Financial Results
-
Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia
-
Route 92 Medical Appoints Medtech Industry Leader Pat Mackin to its Board of Directors
-
Solmate Infrastructure (SLMT) Launches the UAE’s First Performant Solana Validator, Announces Infrastructure Flywheel™ Including Planned RPC and Colocation Services
-
Ascent Solar Technologies and CisLunar Industries Enter Teaming Agreement to Bring Power Solutions that Lengthen Missions to U.S. Space Market
-
Iovance Biotherapeutics Highlights Business Achievements, Pipeline Milestones, and Third Quarter 2025 Results
-
CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy
-
BitFuFu Announces Sponsorship of Mining Disrupt 2025 in Dallas
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Jamf Holding Corp. (Nasdaq – JAMF), CSG Systems International, Inc. (Nasdaq – CSGS), Olympic Steel, Inc. (N
-
Dentsply Sirona Reports Third Quarter 2025 Results
-
Webinar to Explore Solutions for Sustainable Energy and Technology to Power a Resilient Economy
-
Solid Biosciences Awarded Innovation Passport Designation Under the New UK Innovative Licensing and Access Pathway for SGT-003, an Investigational Gene Therapy for Duchenne Muscular Dystrophy
-
Nanox Collaborates with Leading Czech Medical Imaging Distributor EXRAY to Expand European Footprint
-
Upexi to Host First Quarter 2026 Earnings Call on November 11th at 5:30 p.m. ET
-
Terra Innovatum Global to Report Third Quarter 2025 Financial Results and Provide Business Update on November 17, 2025
-
Feed a Family of 10 for Under $40 this Thanksgiving: Stop & Shop Introduces One of the Season’s Best Dinner Deals
-
Darktrace Recognized as the Only Customer’s Choice Vendor in the 2025 Gartner® Peer Insights™ for Network Detection and Response
-
UroGen Reports Third Quarter 2025 Financial Results as ZUSDURI™ Launch Gains Momentum
-
iOThree Limited Announces 1-for-10 Reverse Share Split
-
Hatteras Venture Partners Honors HistoSonics with the Charles A. Sanders Award for Entrepreneurial Excellence
-
Lisata Therapeutics Wins 2025 BioTech Breakthrough Award for ‘Overall BioPharma Solution of the Year’
-
Gaxos Labs Launches “Photoshoots,” Bringing Studio-Grade AI Photography to Art-Gen
-
Sironax Announces Three Abstracts Selected for Presentation at Neuroscience 2025
-
AUKEY Partners with the Brooklyn Nets for an Electrifying NBA Season
-
OptimumBank Holdings, Inc., to Announce Third Quarter 2025 Results and Host Earnings Webcast on November 13, 2025
-
Veriff Report: Impersonation fraud is a persistent threat to the success of mobility and gig economy platforms
-
Nasus Pharma Announces Approval from Health Canada to Initiate Planned Phase 2 Clinical Study of NS002 Intranasal Epinephrine Powder
-
Inriver Expands Connected Ecosystem for Product Content Distribution Through New Partnerships with Shopify and Affiliated Distributors
-
Remote Monitoring and Control Provider Acorn’s Nine-Month EPS Rose 35.7% to $0.57 Driven by 22% Revenue Increase; Investor Call today at 11am ET
-
Mobiquity Technologies’ Platform Powers New Context Networks–NRT Partners to Bring Dynamic Digital Advertising to 1,000+ Casinos Worldwide
-
UroGen Reports 77.8% Three-Month Complete Response Rate from Phase 3 UTOPIA Trial of UGN-103 and Receives FDA Agreement on NDA Submission Strategy in Recurrent LG-IR-NMIBC Based on UTOPIA Trial
